Senate confirms Trump health secretary

The Department of Health and Human Services (HHS) has a new boss, Alex Azar, after nearly four months without a permanent leader.

The Senate confirmed Azar, a former pharmaceutical executive, on Wednesday by a 55-43 vote with six Democrats and Independent Sen. Angus KingAngus Stanley KingHillicon Valley: Washington preps for Mueller report | Barr to hold Thursday presser | Lawmakers dive into AI ethics | FCC chair moves to block China Mobile | Dem bill targets 'digital divide' | Microsoft denies request for facial recognition tech Dems introduce bill to tackle 'digital divide' Collins receives more donations from Texas fossil fuel industry than from Maine residents MORE (Maine) joining all but one Republican to support the nominee.

Sen. Rand PaulRandal (Rand) Howard PaulTrump vetoes measure ending US support for Saudi-led war in Yemen Bottom line Trump: I have not read Mueller report, 'though I have every right to do so' MORE (R-Ky.) was the lone Republican to vote against his confirmation, after having previously expressed concern over Azar's reticence to let drugs be imported from overseas.

Azar replaces Tom PriceThomas (Tom) Edmunds PriceOvernight Health Care: CEO of largest private health insurer slams 'Medicare for All' plans | Dem bill targets youth tobacco use | CVS fined over fake painkiller prescriptions | Trump, first lady to discuss opioid crisis at summit HHS inspector general stepping down from watchdog role Ex-GOP lawmaker Handel to run for her former Georgia seat in 2020 MORE, who resigned in September after Politico detailed repeated trips he took on private and military jets, costing taxpayers more than $1 million.

ADVERTISEMENT

Democrats have attacked Azar over drug prices — saying the cost of several drugs more than doubled during his time at Eli Lilly — and expressed concern that he would continue what they view as the Trump administration’s attempts to sabotage ObamaCare.

Meanwhile, Republicans cast Azar’s nearly 10 year tenure at Eli Lilly, where he served as president of Lilly USA from 2012 to 2017 years, as an asset because he already knows the ins and outs of such a complex industry.

Azar will take the helm of the massive department at a critical juncture for ObamaCare. It’s unlikely congressional Republicans will return to the difficult task of repealing and replacing President Obama’s signature health-care law, leaving the White House to seek changes on its own through administrative action.

Azar knows the regulatory process well. Under former President George W. Bush, he served HHS as general counsel from 2001 to 2005. He then became deputy secretary for two years under Secretary Mike Leavitt, who asked Azar to oversee the department’s regulatory process.

“He understands the process and he knows the levers and how you make it work and where the potential roadblocks are,” Leavitt told The Hill last year. “I think he would be of particular value given the fact that ... so far a repeal bill has not occurred and they’re going to need to make their imprint on existing laws through replacing the ideology underpinning it.”

Prescription drugs prices are also likely to be discussed under Azar's tenure. Lawmakers have criticized the high costs of prescription drugs, and President TrumpDonald John TrumpHouse Dems demand Barr cancel 'inappropriate' press conference on Mueller report DOJ plans to release 'lightly redacted' version of Mueller report Thursday: WaPo Nadler accuses Barr of 'unprecedented steps' to 'spin' Mueller report MORE has said drug companies were “getting away with murder.” In nomination hearings, Azar said “drug prices are too high.”

But in those hearings, Democrats expressed concerns over Azar’s record as a pharmaceutical executive, and that was, in part, a reason why some senators voted against his confirmation.

“Here’s my view: Mr. Azar’s nomination is a perfect encapsulation of the president’s broken promises on prescription drugs and health care overall,” Sen. Ron WydenRonald (Ron) Lee WydenHillicon Valley: Washington preps for Mueller report | Barr to hold Thursday presser | Lawmakers dive into AI ethics | FCC chair moves to block China Mobile | Dem bill targets 'digital divide' | Microsoft denies request for facial recognition tech Lawmakers, tech set for clash over AI Overnight Energy: Collins receives more donations from Texas oil, gas industry than from Maine residents | Interior chief left meetings off schedule | Omar controversy jeopardizes Ocasio-Cortez trip to coal mine MORE (D-Ore.), the top Democrat on the Senate Finance Committee, said in a press release ahead of a procedural vote on Azar’s confirmation.

The panel’s chairman, Sen. Orrin HatchOrrin Grant HatchHatch warns 'dangerous' idea of court packing could hurt religious liberty Former Democratic aide pleads guilty to doxing GOP senators attending Kavanaugh hearing How do we prevent viral live streaming of New Zealand-style violence? MORE (R-Utah) has countered that Azar has the right experience to helm HHS, which oversees everything from Medicare and Medicaid to drug approvals and disease control.

“Mr. Azar spent several years as a senior official at HHS, holding key positions overseeing Medicare Part D and Medicare Advantage. He also led HHS’s responses to the anthrax attacks shortly after 9/11, the SARS and monkeypox crises, Hurricane Katrina, and many others,” Hatch said in a press release ahead of the confirmation vote.

“Clearly, Mr. Azar has seen both the good and bad at HHS and knows how to manage them. I don’t think there is anyone here, even on the other side of the aisle, who would contest that.”

The six Democrats who voted for Azar are Sens. Tom CarperThomas (Tom) Richard CarperOnly four Dem senators have endorsed 2020 candidates Koch network launches ad campaign opposing Trump's proposed gas tax Big Dem names show little interest in Senate MORE (Del.), Christopher CoonsChristopher (Chris) Andrew CoonsMenendez, Rubio lead Senate effort to regulate Venezuelan sanctions Dem report questions State Dept. decision to revoke award to Trump critic Senate Dem calls on Trump to apologize for attacks on McCain MORE (Del.), Joe DonnellyJoseph (Joe) Simon DonnellySome in GOP fear Buttigieg run for governor Paul Ryan joins University of Notre Dame faculty GOP senator issues stark warning to Republicans on health care MORE (Ind.), Heidi HeitkampMary (Heidi) Kathryn HeitkampPro-trade groups enlist another ex-Dem lawmaker to push for Trump's NAFTA replacement Pro-trade group targets 4 lawmakers in push for new NAFTA Biden office highlights support from women after second accuser comes forward MORE (N.D.), Doug Jones (Ala.) and Joe ManchinJoseph (Joe) ManchinOn The Money: Cain 'very committed' to Fed bid despite opposition | Pelosi warns no US-UK trade deal if Brexit harms Irish peace | Ivanka Trump says she turned down World Bank job Cain says he won't back down, wants to be nominated to Fed Pro-life Christians are demanding pollution protections MORE (W.Va.).